Acquisition of Biocomposites Ltd.

Healthcare
Acquisition of Biocomposites Ltd.

Summary

Baird served as exclusive financial advisor to TA Associates

About

TA Associates recently invested in Biocomposites Ltd. (“Biocomposites” or “the Company”). The former shareholders, existing of the Company founders and private investors, have sold the majority of its investment, while also reinvesting a considerable share. Terms of the transaction were not disclosed.

TA Associates is one of the largest and most experienced global growth private equity firms. TA Associates has invested in more than 480 companies around the world and has raised $24 billion in capital. With offices in Boston, Menlo Park, London, Mumbai and Hong Kong, TA Associates leads buyouts and minority recapitalisations of profitable growth companies in the business services, consumer, financial services, healthcare and technology industries. TA Associates is headquartered in Boston, Massachusetts.

Biocomposites is a manufacturer and marketer of calcium compound biologics, singularly focused on the development of innovative calcium compounds for surgical use. The Company’s bone graft matrices can be used in the presence of infection for regenerating bone and managing dead space in a range of orthopedic procedures. Biocomposites sells directly to hospitals and through independent distributors, with the United States representing its largest market. Research, manufacturing and distribution is handled in-house at the Company’s headquarters in Keele, the United Kingdom. Sales representative offices are also maintained in Wilmington, North Carolina and Shanghai, China.
CONTACT US TO LEARN MORE
Healthcare
Acquisition of Biocomposites Ltd.
Date
May 2017
Company
TA Associates
Transaction
M&A
Sectors
Healthcare
Target Location
North America
Acquiror Location
Europe

Share